<DOC>
	<DOCNO>NCT00672841</DOCNO>
	<brief_summary>This single center , prospective , open label assessment β-D-glucan surveillance preemptive anidulafungin therapy versus standard care prevention invasive candidiasis at-risk surgical intensive care unit ( SICU ) patient . Subjects stratify APACHE II score randomized 3:1 fashion either biweekly surveillance use β-D-glucan assay standard care . Subjects active monitoring arm receive intravenous anidulafungin β-D-glucan exceed 60 pg/mL single determination . Subjects standard care arm biweekly blood draws β-D-glucan , specimen batch test retrospectively . Antifungal use standard care arm discretion treat physician . The primary study end-points feasibility preemptive antifungal strategy SICU setting , β-D-glucan test characteristic , safety tolerability preemptive anidulafungin . Risks associate study participation include risk associate blood draw , study drug relate side effect , potential loss confidentiality .</brief_summary>
	<brief_title>β-D-Glucan ( BDG ) Surveillance With Preemptive Anidulafungin vs. Standard Care Invasive Candidiasis Surgical Intensive Care Unit ( SICU ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Invasive</mesh_term>
	<mesh_term>Antifungal Agents</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<mesh_term>Anidulafungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Age ≥18 year Admission intensive care unit ≥ 72 hour expect stay additional 48 hour IV access administration study drug Subject ( subject 's legal representative ) able give write informed consent History hypersensitivity intolerance echinocandin antifungal Liver function test ( ALT , AST ( aspartate aminotransferase ) , and/or total bilirubin ) great 10 time upper limit normal ( ULN ) Pregnant lactate woman Treatment systemic antifungal therapy within precede 7 day Documented invasive fungal infection baseline/screening Life expectancy le 2 day moribund</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>candidemia</keyword>
	<keyword>invasive candidiasis</keyword>
	<keyword>preemptive antifungal therapy</keyword>
	<keyword>surveillance</keyword>
	<keyword>β-D-Glucan ( BDG )</keyword>
</DOC>